Management and Epidemiology of Patients Admitted in ICU
Conditions
Brief summary
Multicentre, national, observational, retrospective and prospective study. The BLITZ-COVID19 study aims at describing the epidemiology of admissions to Italian Cardiology Intensive Care Units in the COVID-19 infection pandemia, the main aspects of the clinical management of inpatients, their short-term outcome, the absorption of resources related to their admission.
Detailed description
The BLITZ-COVID19 study, aims at describing the epidemiology of admissions to Italian Cardiology Intensive Care Units . The study is observational, multicentre, national and involves the collection of clinical data, both retrospectively and prospectively, using a web-based system. In conducting the study, no drugs are tested, nor are diagnostic tests or non-pharmacological therapies performed other than those that each participating cardiologist decides to perform following the rules of normal clinical practice. Diagnostic procedures and pharmacological and non-pharmacological therapies habitually prescribed for cardiovascular pathologies, which are the object of hospitalization, and those used in the event of a COVID-19 infection, will be recorded in the database.
Interventions
OTHEREpidemiology of admissions
Cardiology Intensive Care Unit admission
Sponsors
Heart Care Foundation
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
\- All patients aged ≥18 years admitted with any diagnosis to one of the participating ICU
Exclusion criteria
\- Refuse to signe consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Impact that COVID-19 infection may have had on the in-hospital mortality | Enrollment | Impact that COVID-19 infection may have had on the in-hospital mortality of the various clinical conditions admitted to ICU |
| Epidemiology and management of patients admitted to ICU | Enrollment | The different diagnoses of discharge from the ICU and their frequency will be described. All hospitalized cardiac and non-cardiac pathologies will be listed, with particular reference to any COVID-19 infection. |
| Management of patients admitted to ICU | Enrollment | Description of the main therapeutic decision in patients hospitalized for the most relevant pathologies |
Countries
Italy
Outcome results
None listed